207
Views
2
CrossRef citations to date
0
Altmetric
Article

Mesomorphic properties of fluorinated cholesteric three-arm liquid crystals based on chenodeoxycholic acid

, &
Pages 2234-2246 | Received 03 Mar 2020, Accepted 30 Apr 2020, Published online: 22 May 2020
 

ABSTRACT

Five non-symmetric three-arm liquid crystals (LCs) based on chenodeoxycholic acid (CDCA), termed as EFSD, EFSL, EFXD, EFXL and EFDZ, were synthesised. EF, which is a chiral smectic A (SmA*) LC, was synthesised by using CDCA as the chiral core and introducing fluorinated LC arm, 4ʹ-((10-chloro-10-oxodecanoyl)oxy)-[1,1ʹ- biphenyl]-4-yl 4-(trifluoromethyl)benzoate, into the hydroxyl of CDCA. The third side arm with different rigidity and the length of the terminal chain was introduced into the carboxyl group of CDCA to prepare the non-symmetric three-arm LCs. The results indicate that the proper increase of the third side arm’s rigidity can stabilise the LC phases and widen LC ranges. In addition, the structure of the third side arm also had an influence on the LC phase type. EFSD, EFXD, EFXL and EFDZ display cholesteric (Ch) phases, while EFSL exhibits chiral smectic C (SmC*) phase. The longer alkyl terminal chain of the third side arm can lead to the appearance of lamellar phase. For this type LCs, it is beneficial to the formation of Ch phase LCs to adopt short alkyl terminal chain. That EFDZ displays Ch phase may be due to the increase of molecular biaxiality of EFDZ due to the biaxiality of cholesterol.

Graphical abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the Fundamental Research Funds for the Central Universities: [Grant Number N180705004 and N182410001 (Northeastern University Training Program Self-raised Project (191052) of Innovation and Entrepreneurship for Undergraduates)].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.